B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Pralsetinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Pralsetinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

entospletinib
2 shared targets
entrectinib
3 shared targets
whi
2 shared targets
go
2 shared targets
semaxanib
2 shared targets
merestinib
2 shared targets
cerdulatinib
3 shared targets
bemcentinib
2 shared targets
mk
3 shared targets
azd
3 shared targets
Loading evidence profile...

This evidence profile for Pralsetinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.